Masimo (MASI) Debt to Equity (2013 - 2026)
Masimo's quarterly Debt to Equity came in at $0.56 in Q2 2026, down 15.93% year-on-year from $0.67 in Q2 2025, and down 21.34% quarter-over-quarter from $0.72 in Q1 2026.
Masimo has reported Debt to Equity for 9 years, with the latest figure at $0.56 in Q2 2026.
- For the quarter ending Q2 2026, Debt to Equity fell 15.93% year-over-year to $0.56; the trailing twelve-month figure through Apr 2026 stood at $0.56 (down 15.93% YoY), and the FY2026 full-year result was $0.72, up 5.77% from the prior year.
- Debt to Equity for Q2 2026 stood at $0.56, down from $0.72 in the prior quarter.
- The five-year high for Debt to Equity was $0.77 in Q3 2022, with the low at $0.5 in Q3 2024.
- Average Debt to Equity over 5 years is $0.66, with a median of $0.68 recorded in 2024.
- Year-over-year, Debt to Equity decreased 29.77% in 2024 and jumped 37.75% in 2025.
- Tracing MASI's Debt to Equity over 5 years: stood at $0.7 in 2022, then fell by 9.18% to $0.64 in 2023, then climbed by 6.32% to $0.68 in 2024, then advanced by 1.65% to $0.69 in 2025, then declined by 18.15% to $0.56 in 2026.
- The last three Debt to Equity figures came in at $0.56 (Q2 2026), $0.72 (Q1 2026), and $0.69 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.65 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.64 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.57 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.42 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.06 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.95 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.27 |
| 10 | Masimo | 9.32 Bn | 9.20 Bn | 250.80 Mn | 0.56 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 0.56 |
| Jan 3, 2026 | 0.72 |
| Sep 27, 2025 | 0.69 |
| Jun 28, 2025 | 0.57 |
| Mar 29, 2025 | 0.67 |
| Dec 28, 2024 | 0.68 |
| Sep 28, 2024 | 0.50 |
| Jun 29, 2024 | 0.55 |
| Mar 30, 2024 | 0.62 |
| Dec 30, 2023 | 0.64 |
| Sep 30, 2023 | 0.71 |
| Jul 1, 2023 | 0.68 |
| Apr 1, 2023 | 0.67 |
| Dec 31, 2022 | 0.70 |
| Oct 1, 2022 | 0.76 |
| Jul 2, 2022 | 0.77 |
| Oct 1, 2016 | 0.46 |
| Jul 2, 2016 | 0.59 |
| Apr 2, 2016 | 0.84 |
| Jan 2, 2016 | 0.64 |
| Oct 3, 2015 | 0.71 |
| Jul 4, 2015 | 0.63 |
| Apr 4, 2015 | 0.39 |
| Jan 3, 2015 | 0.41 |
| Sep 27, 2014 | 0.44 |
| Jun 28, 2014 | 0.24 |
| Dec 28, 2013 | 0.00 |